Atlas Trials

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

Clinical trial NCT06448286 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06448286
Sponsor
Jonsson Comprehensive Cancer Center
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Glioblastoma
Start date
2026-12-01
Primary completion
2030-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.